Brian D. Adkins

588 total citations
61 papers, 253 citations indexed

About

Brian D. Adkins is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Brian D. Adkins has authored 61 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 13 papers in Genetics and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Brian D. Adkins's work include Blood groups and transfusion (21 papers), Hemoglobinopathies and Related Disorders (13 papers) and Erythrocyte Function and Pathophysiology (9 papers). Brian D. Adkins is often cited by papers focused on Blood groups and transfusion (21 papers), Hemoglobinopathies and Related Disorders (13 papers) and Erythrocyte Function and Pathophysiology (9 papers). Brian D. Adkins collaborates with scholars based in United States, Canada and Australia. Brian D. Adkins's co-authors include Garrett S. Booth, Jeremy W. Jacobs, Laura D. Stephens, Quentin Eichbaum, Kai Michaelis, Steffi Oesterreich, Mohamed Mokhtar Desouki, Stephen J. Schultenover, Andrew Barlow and Deva Sharma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular and Cellular Biology and BMJ.

In The Last Decade

Brian D. Adkins

46 papers receiving 248 citations

Peers

Brian D. Adkins
Sangeeta Pathak United Kingdom
Farah Sethna Australia
Amir Steinberg United States
Julie Katz Karp United States
Larisa Broglie United States
Sangeeta Pathak United Kingdom
Brian D. Adkins
Citations per year, relative to Brian D. Adkins Brian D. Adkins (= 1×) peers Sangeeta Pathak

Countries citing papers authored by Brian D. Adkins

Since Specialization
Citations

This map shows the geographic impact of Brian D. Adkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian D. Adkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian D. Adkins more than expected).

Fields of papers citing papers by Brian D. Adkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian D. Adkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian D. Adkins. The network helps show where Brian D. Adkins may publish in the future.

Co-authorship network of co-authors of Brian D. Adkins

This figure shows the co-authorship network connecting the top 25 collaborators of Brian D. Adkins. A scholar is included among the top collaborators of Brian D. Adkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian D. Adkins. Brian D. Adkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nero, Alecia, et al.. (2025). Hyperhemolysis in a sickle cell disease patient in pregnancy. Annals of Hematology. 104(8). 4245–4249.
2.
Jacobs, Jeremy W., Jerome J. Federspiel, Melissa Funaro, et al.. (2025). The Utility of a Critical Antibody Titer in Anti-K Alloimmunized Pregnancies: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. Transfusion Medicine Reviews. 39(2). 150895–150895.
3.
Adkins, Brian D., Valerie A. Fitzhugh, Peter Walker, et al.. (2024). Paying to publish: A cross-sectional analysis of article processing charges and journal characteristics among 87 pathology journals. Academic Pathology. 11(4). 100153–100153. 1 indexed citations
4.
Adkins, Brian D., Garrett S. Booth, Ross M. Fasano, et al.. (2024). Eliminating leukocyte reduction for whole blood: Is it premature to consider this paradigm‐changing practice?. Transfusion. 65(2). 375–378.
5.
Jacobs, Jeremy W., Garrett S. Booth, Eleni Gavriilaki, et al.. (2024). Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions. American Journal of Hematology. 99(12). 2351–2366. 8 indexed citations
6.
Jacobs, Jeremy W., Garrett S. Booth, Kenneth J. Moise, et al.. (2024). Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States. Transfusion. 64(10). 1870–1880.
7.
Adkins, Brian D., et al.. (2024). How do we manage hyperhemolysis syndrome. Transfusion. 64(10). 1822–1829.
8.
Ipe, Tina S., Yvette C. Tanhehco, Garrett S. Booth, & Brian D. Adkins. (2024). Gender differences in scholarly productivity of early‐career transfusion medicine physicians. Vox Sanguinis. 119(5). 490–495. 1 indexed citations
9.
Jacobs, Jeremy W., et al.. (2024). Crizanlizumab and sickle cell disease: When should medications have their approval status revoked?. American Journal of Hematology. 99(6). 1016–1018. 6 indexed citations
10.
Adkins, Brian D., Jeremy W. Jacobs, Garrett S. Booth, Bipin N. Savani, & Laura D. Stephens. (2024). Transfusion Support in Hematopoietic Stem Cell Transplantation: A Contemporary Narrative Review. PubMed. 6(1). 128–140. 2 indexed citations
11.
Jacobs, Jeremy W., et al.. (2023). Blood bans and COVID-19: Government attempts to influence medicine and science threaten us all. American Journal of Clinical Pathology. 160(4). 435–436. 3 indexed citations
12.
Jacobs, Jeremy W., et al.. (2023). Clinical and epidemiological features of paroxysmal cold hemoglobinuria: a systematic review. Blood Advances. 7(11). 2520–2527. 16 indexed citations
13.
Stephens, Laura D., Jeremy W. Jacobs, Brian D. Adkins, & Garrett S. Booth. (2023). Battle of the (Chat)Bots: Comparing Large Language Models to Practice Guidelines for Transfusion-Associated Graft-Versus-Host Disease Prevention. Transfusion Medicine Reviews. 37(3). 150753–150753. 21 indexed citations
14.
Jacobs, Jeremy W., Matthew S. Karafin, Elizabeth S. Allen, et al.. (2022). Blood conservation strategies at United States hospitals during the COVID‐19 pandemic: Findings from a multi‐institutional analysis ‐ International Society of Blood Transfusion survey. Transfusion. 62(11). 2271–2281. 8 indexed citations
15.
Jacobs, Jeremy W., et al.. (2022). Gender Inequities in Transfusion Medicine Society Recognition Awards. Transfusion Medicine Reviews. 36(2). 82–86. 7 indexed citations
16.
Adkins, Brian D., et al.. (2020). Low rates of anti-recipient isohemagglutinins in ABO incompatible hematopoietic stem cell transplants. Transfusion and Apheresis Science. 60(1). 102965–102965. 4 indexed citations
17.
Adkins, Brian D., Garrett S. Booth, & Sumithira Vasu. (2020). Transfusion support for stem cell transplant recipients. Seminars in Hematology. 57(2). 51–56. 4 indexed citations
18.
Adkins, Brian D., Deva Sharma, & Quentin Eichbaum. (2019). Can we better predict delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease?. Transfusion and Apheresis Science. 59(2). 102681–102681. 4 indexed citations
19.
Adkins, Brian D., Juan Carlos Ramos, Meghan Bliss‐Moreau, & Alejandro A. Gru. (2019). Updates in lymph node and skin pathology of adult T-cell leukemia/lymphoma, biomarkers, and beyond. Seminars in Diagnostic Pathology. 37(1). 1–10. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026